http://xh.ccbcht.com
Home > Imveliso > I-Varicella Vaccine (Live) > Iimveliso ezigqityiweyo > Finished Products of Chicken Pox Vaccine Lyophilized Live

Finished Products of Chicken Pox Vaccine Lyophilized Live

Ulwazi oluSiseko

Umzekelo No.: 0.5ml/vial

Ingcaciso yeMveliso

The Varicella zoster vaccine is made from the Oka/Merck strain of live attenuated varicella virus. The virus was initially obtained from a child with natural varicella, introduced into human embryonic lung cell cultures, adapted to and propagated in embryonic guinea pig cell cultures, and finally propagated in human diploid cell cultures.

Japan was among the first countries to vaccinate for chickenpox. Routine vaccination against varicella zoster virus is also performed in the United States, and the incidence of chickenpox has been dramatically reduced there (from 4 million cases per year in the pre-vaccine era to approximately 400,000 cases per year as of 2005). In Europe most countries do not currently vaccinate against varicella, though the vaccine is gaining wider acceptance. Australia, Canada, and other countries have adopted recommendations for routine immunization of children and susceptible adults against chickenpox.

Other countries, such as the United Kingdom, have targeted recommendations for the vaccine, e.g., for susceptible health care workers at risk of varicella exposure. In the UK, varicella antibodies are measured as part of the routine of prenatal care, and by 2005 all National Health Service personnel had determined their immunity and been immunized if they were non-immune and have direct patient contact. Population-based immunization against varicella is not otherwise practised in the UK.

Varicella Vaccine

Iikhathalo zomkhiqizo : I-Varicella Vaccine (Live) > Iimveliso ezigqityiweyo

I-imeyili kule mthengisi
  • *Isihloko:
  • *Imiyalezo:
    Umyalezo wakho kufuneka ube phakathi kweenhlamvu ezingama-20-8000
Ukunxibelelana noMthengisi?Umthengisi
Alice Zhang Ms. Alice Zhang
Ndingakwenzela ntoni?
Qhagamshelana noMthengisi